Allergic Conjunctivitis Market Share, Growth, Challenges, & Global Forecast

1
Allergic Conjunctivitis Market
Allergic Conjunctivitis Market
2
Report Description and Highlights
Allergic conjunctivitis is common ophthalmic
disorder caused by reactions to allergens like
pollen or mold spores, dust mites and animal fur.
The eyeball has a membrane called conjunctiva
which is receptive towards the irritation from
allergens. In July 2020, IACTA Pharmaceuticals
Zhaoke Ophthalmology Pharmaceuticals Ltd has
signed an agreement to accelerate the development
of drugs called IC265 and IC 270. Earlier they
were develop to treat dry eye and later for
allergic conjunctivitis. There are many types of
allergic conjunctivitis such as seasonal allergic
conjunctivitis is caused by airborne mold spores,
spring, late summer, or early fall and disappear
during the winter month perennial allergic
conjunctivitis is caused by dust, mites, animal
dander, and other non-seasonal allergens. Accordi
ng to Renub Research, Allergic Conjunctivitis
Market was US 1.5 Billion in 2020 is expected to
grow with a CAGR of 8.81 and reach US 2.7
Billion by 2027.
Allergic Conjunctivitis Market
3
Allergic Conjunctivitis Market
Allergic Conjunctivitis Market 2020 - 2027
Allergic Conjunctivitis Market
4
Allergic Conjunctivitis Market
There has been significant increase allergic
conjunctivitis due to increase in the use of
chemicals and pollution caused by urbanization,
industrialization and climate change. The
increase in awareness of allergic conjunctivitis
is associated its medical treatment upcoming
therapies such as Zerviate, ADX-102, PRT-2761,
OTX-DP etc. is one of the factors driving the
market. Many Pharmaceutical companies are trying
to develop many new possibilities of treatment
for allergic conjunctivitis such as Zerviate,
EM-100, ADX-102, PRT-2761, and OTX-DP. For
instance, EyeMax LLCs EM-100 is currently in
phase 3 of clinical trial, where its
effectiveness is being checked in the treatment
of ocular itching. Presently, around two third of
new treatment options are in phase 2 or 3 of
clinical trials.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lallergic-conjunctivitis-market-p.php
Allergic Conjunctivitis Market
5
Allergic Conjunctivitis Market
We have studied by region of North America
followed by Europe and Asia-Pacific. The allergic
conjunctivitis treatment market in Asia Pacific
is expected to grow rapidly, due to having a
large population base and increased demand of
improved health facilities. Renub
Research report titled Global Allergic
Conjunctivitis Market, Patients, Treated Patients
By Countries (India, China, Japan, United States,
United Kingdom, France, Germany, Italy, Spain),
Disease Type (Seasonal Allergic Conjunctivitis
(SAC) Perennial Allergic Conjunctivitis (PAC),
Vernal Kerato Conjunctivitis (VKC), Atopic Kerato
Conjunctivitis (AKC) And Giant Papillary
Conjunctivitis (GPC)), Drugs Profile (Zerviate,
OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002,
Bertilimumab, Reproxalap, ST-266, SYL-116011)
Companies (Santen Pharmaceutical, Alcon
(Novartis), Portola Pharmaceuticals, Ocular
Therapeutix), Growth Drivers, Challenges provides
a complete analysis of global allergic
conjunctivitis market.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlallergic-conjunctivitis-market-p.php
Allergic Conjunctivitis Market
6
Allergic Conjunctivitis Market
Global Allergic Conjunctivitis Market has been
analyzed from 9 Major Viewpoints     Market -
 Global Allergic Conjunctivitis    Market
Share, Disease Type Market Share, Patients Share,
Treated Patients Share    Market - Country
Allergic Conjunctivitis    Patients Population
- Country Allergic Conjunctivitis    Country
Allergic Conjunctivitis Treated Patients
Population    Disease Type -  Allergic
Conjunctivitis Market    Drugs Pipeline -
Allergic Conjunctivitis    Key Growth factors
and Challenges    Key Companies Initiatives and
Financial Insights Country Market breakup from
9 viewpoints     India     China   
 Japan     United States     United
Kingdom    France     Germany     Italy   
 Spain
Allergic Conjunctivitis Market
7
Allergic Conjunctivitis Market
Disease Market Breakup from4 viewpoints   
 Seasonal Allergic Conjunctivitis (SAC)
Perennial Allergic Conjunctivitis (PAC)  
 Vernal Kerato Conjunctivitis (VKC)    Atopic
Kerato Conjunctivitis (AKC)    Giant Papillary
Conjunctivitis (GPC) Drugs Market Breakup from
10 viewpoints     Zerviate     OTX-DP  
 ADX-102     PRT-2761    CVXL-0074   
 AK-002    Bertilimumab     Reproxalap  
 ST-266     SYL-116011
Allergic Conjunctivitis Market
8
Allergic Conjunctivitis Market
Global Analysis - Allergic Conjunctivitis Market
Forecast for (2021 - 2027)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
Allergic Conjunctivitis Market
9
Allergic Conjunctivitis Market
All companies has been covered from 3
viewpoints     Overviews    Recent
Developments    Revenues Company Covered   
 Santen Pharmaceutical    Alcon (Novartis)  
 Portola Pharmaceuticals    Ocular Therapeutix
Allergic Conjunctivitis Market
10
Allergic Conjunctivitis Market
Allergic Conjunctivitis Market
11
Contact Us
Allergic Conjunctivitis Market